BLUE · Categories · Form 4

BLUE - SEC Form 4 insider transactions

bluebird bio Inc. (BLUE) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for BLUE

• 371d
  Chief Business & Legal Officer Vittiglio Joseph returned 5,625 shares to the company and was granted 2,500 shares, closing all direct ownership in the company (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 371d
  Director Agwunobi John O returned 1,245 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 371d
  Director Vachon Mark returned 1,245 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 371d
  Chief Medical Officer Colvin Richard A returned 6,666 shares to the company and was granted 2,500 shares, closing all direct ownership in the company (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 371d
  Director Tita-Reid Najoh returned 1,245 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 371d
  President and CEO Obenshain Andrew returned 24,120 shares to the company and was granted 14,820 shares, closing all direct ownership in the company (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 371d
  Director Leiderman Elisabeth returned 1,245 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 371d
  Director Jones-Burton Charlotte returned 1,245 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 371d
  Officer Klima Thomas J returned 6,964 shares to the company and was granted 2,500 shares, closing all direct ownership in the company (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 371d
  Chief Financial Officer Sterling O. James returned 7,500 shares to the company and was granted 2,500 shares, closing all direct ownership in the company (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 371d
  Director Leschly Nick returned 1,245 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 371d
  Director Paulson Richard A. returned 1,323 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 371d
  Director Cloonan Michael returned 1,867 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 462d
  Chief Medical Officer Colvin Richard A sold $2,289 worth of shares (584 units at $3.92), decreasing direct ownership by 7% to 7,610 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 462d
  Officer Klima Thomas J sold $1,960 worth of shares (500 units at $3.92), decreasing direct ownership by 6% to 7,878 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 462d
  President and CEO Obenshain Andrew sold $3,610 worth of shares (921 units at $3.92), decreasing direct ownership by 5% to 18,327 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 482d
  President and CEO Obenshain Andrew was granted 763 shares, increasing direct ownership by 4% to 19,248 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 489d
  Officer Klima Thomas J sold $902 worth of shares (122 units at $7.39), decreasing direct ownership by 1% to 8,378 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 489d
  Chief Medical Officer Colvin Richard A sold $473 worth of shares (64 units at $7.39), decreasing direct ownership by 0.78% to 8,194 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 489d
  Chief Business & Legal Officer Vittiglio Joseph sold $1,759 worth of shares (238 units at $7.39), decreasing direct ownership by 5% to 4,501 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 489d
  President and CEO Obenshain Andrew sold $636 worth of shares (86 units at $7.39), decreasing direct ownership by 0.46% to 18,485 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 518d
  Chief Medical Officer Colvin Richard A sold $176 worth of shares (19 units at $9.24) (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 518d
  President and CEO Obenshain Andrew sold $1,294 worth of shares (140 units at $9.24), decreasing direct ownership by 0.75% to 18,571 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 545d
  Chief Medical Officer Colvin Richard A sold $1,178 worth of shares (2,824 units at $0.42), decreasing direct ownership by 2% to 165,544 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 545d
  President and CEO Obenshain Andrew sold $405 worth of shares (971 units at $0.42), decreasing direct ownership by 0.26% to 374,247 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 578d
  Director Tita-Reid Najoh was granted 24,900 shares, increasing direct ownership by 107% to 48,160 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 578d
  Director Paulson Richard A. was granted 24,900 shares, increasing direct ownership by 534% to 29,563 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 579d
  Director Agwunobi John O was granted 24,900 shares, increasing direct ownership by 94% to 51,364 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 578d
  Director Leschly Nick was granted 24,900 shares, increasing direct ownership by 9% to 315,839 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 578d
  Director Jones-Burton Charlotte was granted 24,900 shares, increasing direct ownership by 134% to 43,462 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 579d
  Director Leiderman Elisabeth was granted 24,900 shares, increasing direct ownership by 112% to 47,156 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 579d
  Director Vachon Mark was granted 24,900 shares, increasing direct ownership by 99% to 49,941 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 616d
  Chief Medical Officer Colvin Richard A was granted 50,000 shares, increasing direct ownership by 42% to 168,368 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 616d
  Chief Business & Legal Officer Vittiglio Joseph was granted 50,000 shares, increasing direct ownership by 112% to 94,783 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 616d
  Director Cloonan Michael was granted 37,350 shares (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 616d
  Chief Financial Officer Sterling O. James was granted 100,000 shares (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 616d
  Officer Klima Thomas J was granted 50,000 shares and sold $529 worth of shares (1,006 units at $0.53), increasing direct ownership by 40% to 170,000 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 616d
  President and CEO Obenshain Andrew was granted 130,000 shares and sold $18,270 worth of shares (34,780 units at $0.53), increasing direct ownership by 34% to 375,218 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 707d
  SEC Form 4 filed by Chief Financial Officer Sterling O. James

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 715d
  SEC Form 4 filed by Director Cloonan Michael

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 736d
  Klima Thomas J sold $3,726 worth of shares (3,834 units at $0.97), decreasing direct ownership by 3% to 121,006 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 826d
  Colvin Richard A sold $10,342 worth of shares (6,770 units at $1.53), decreasing direct ownership by 5% to 118,368 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 826d
  Obenshain Andrew sold $9,311 worth of shares (6,095 units at $1.53), decreasing direct ownership by 2% to 279,998 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 826d
  SEC Form 4 filed by Vittiglio Joseph

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 826d
  SEC Form 4 filed by Krawtschuk Christopher

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 826d
  Klima Thomas J sold $6,986 worth of shares (4,573 units at $1.53), decreasing direct ownership by 4% to 124,840 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 855d
  Klima Thomas J sold $2,449 worth of shares (2,714 units at $0.90), decreasing direct ownership by 2% to 129,413 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 855d
  Vittiglio Joseph sold $4,708 worth of shares (5,217 units at $0.90), decreasing direct ownership by 10% to 44,783 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 855d
  Obenshain Andrew sold $1,696 worth of shares (1,879 units at $0.90), decreasing direct ownership by 0.65% to 286,093 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 883d
  Obenshain Andrew sold $4,520 worth of shares (3,162 units at $1.43), decreasing direct ownership by 1% to 287,972 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 883d
  Colvin Richard A sold $845 worth of shares (597 units at $1.42), decreasing direct ownership by 0.47% to 125,138 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 914d
  Krawtschuk Christopher sold $20,437 worth of shares (4,526 units at $4.52), decreasing direct ownership by 9% to 45,474 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 950d
  Obenshain Andrew sold $2,555 worth of shares (807 units at $3.17), decreasing direct ownership by 0.28% to 291,134 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 950d
  Colvin Richard A sold $6,975 worth of shares (2,343 units at $2.98), decreasing direct ownership by 2% to 125,735 units (SEC Form 4)

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 1008d
  SEC Form 4: Klima Thomas J sold $3,493 worth of shares (922 units at $3.79), decreasing direct ownership by 0.69% to 132,127 units

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 1035d
  SEC Form 4: Obenshain Andrew sold $59,956 worth of shares (16,929 units at $3.54), decreasing direct ownership by 5% to 291,941 units

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 1086d
  SEC Form 4 filed by Tita-Reid Najoh

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 1086d
  SEC Form 4 filed by Agwunobi John O

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 1086d
  SEC Form 4 filed by Vachon Mark

  4 - bluebird bio, Inc. (0001293971) (Issuer)
• 1086d
  SEC Form 4 filed by Leiderman Elisabeth

  4 - bluebird bio, Inc. (0001293971) (Issuer)

Other BLUE categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends